BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30587737)

  • 21. [Two cases of radiofrequency ablation (RFA) therapy for control of liver metastases from breast cancer].
    Sato T; Sato S; Kato K; Tsunozaki H; Iwama T; Karasawa K; Takahashi T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1904-6. PubMed ID: 17212142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of paclitaxel and trastuzumab-resistant recurrent breast cancer with liver metastasis responding to S-1].
    Nomura T; Sonoo H; Miyake A; Souda M; Yamamoto Y; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1607-10. PubMed ID: 18799922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Two patients having recurrent breast cancer with brain metastases well controlled with a gamma knife radio-surgery].
    Hojo S; Maeura Y; Yoshioka S; Fujie Y; Fukunaga H; Okada Y; Ota H; Endo W
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1910-2. PubMed ID: 17212144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case of Recurrent Breast Cancer with Complete Response to Eribulin Monotherapy after Bevacizumab plus Paclitaxel Combination Therapy].
    Higashi T; Ozawa K; Takagi S; Onodera Y; Yokoyama M; Mase K; Moriya T; Takeshita A; Mizutani M; Usuba O
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1093-1095. PubMed ID: 30042279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prolonged remission achieved by using bevacizumab plus paclitaxel therapy combined with sequential radiotherapy for a rapidly growing chest wall recurrence of triple negative breast cancer - a case report].
    Kawashima M; Fujii K; Kiso M; Takeyama O; Kan S; Tanaka M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):81-4. PubMed ID: 25596684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A Case of Chemotherapy with Low-Dose Paclitaxel and Bevacizumab for Elderly Recurrent Breast Cancer Patient].
    Munemoto M; Kano S; Ishikawa S; Makita N; Yagi Y; Oonishi I; Kayahara M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2038-2040. PubMed ID: 33468793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.
    Nomura T; Kurebayashi J; Moriya T; Saito W; Murata T; Yamamoto J; Hozumi C; Hoffman RM
    Anticancer Res; 2021 Dec; 41(12):6191-6197. PubMed ID: 34848473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
    Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
    Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A Case of Locally-Advanced Breast Cancer with Liver Metastasis, Treated with Mastectomy of the Primary Tumor after Chemotherapy].
    Kanada Y; Matsuzaki H; Kobayashi H; Suzuki K; Sawada H; Senba Y; Yoshioka T; Note H; Sato Y; Miyazaki A; Natsume T; Tanaka H; Maruyama T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1509-11. PubMed ID: 26805079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case of HER2-Positive Breast Cancer Treated with Nipple-Sparing Mastectomywith Immediate Reconstruction Using a Tissue Expander after Nab-Paclitaxel Combined with Chemotherapy].
    Nonomura A; Aomatsu N; Tei S; Haraoka G; Tsujio G; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2056-2058. PubMed ID: 28133220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher efficacy and complete response with administration of eribulin for recurrent squamous cell breast carcinoma: A case report.
    Goto Y; Yoshida T; Kimura M
    Mol Clin Oncol; 2018 Sep; 9(3):318-320. PubMed ID: 30155255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
    Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
    Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
    Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
    J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy-Resistant Breast Cancer and Carcinomatous Pleuritis Successfully Treated with Abemaciclib plus Letrozole Therapy].
    Nozaki Y; Yamamuro M; Tanaka N; Kamo N; Konishi J
    Gan To Kagaku Ryoho; 2023 Apr; 50(4):477-479. PubMed ID: 37066461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy.
    Park HJ; Shin KH; Cho KH; Park IH; Lee KS; Ro J; Jung SY; Lee S; Kim SW; Kang HS; Chie EK; Ha SW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e689-95. PubMed ID: 21300467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of pregnancy associated breast cancer].
    Székely B; Langmár Z; Somlai K; Szentmártoni G; Szalay K; Korompay A; Szász AM; Kulka J; Bánhidy F; Dank M
    Orv Hetil; 2010 Aug; 151(32):1299-303. PubMed ID: 20656670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.